We are live on
!
Find out more
OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$9.63B
1-Year Est. Return
30.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+329.01%
AUM
$3.62B
AUM Growth
+$109M
(+3.1%)
Cap. Flow
+$29.8M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
1,787
New
81
Increased
723
Reduced
742
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$9.09M |
| 2 |
General Mills
GIS
|
+$8.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.22M |
| 4 |
Cencora
COR
|
+$4.97M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.8M |
| 2 |
DNB
Dun & Bradstreet
DNB
|
+$6.42M |
| 3 |
PNC Financial Services
PNC
|
+$6.23M |
| 4 |
PepsiCo
PEP
|
+$5.76M |
| 5 |
Walt Disney
DIS
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.38% |
| 2 | Healthcare | 15.13% |
| 3 | Technology | 14.47% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1226
DELISTED
Veradigm Inc. Common Stock
MDRX
| $79K | ﹤0.01% |
6,206
+3,897
| +169% | +$47.3K |
|
|
SGEN
1227
DELISTED
Seagen Inc. Common Stock
SGEN
| $78K | ﹤0.01% |
1,511
-2,308
| -60% | -$147K |
|
|
SYNH
1228
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $78K | ﹤0.01% |
1,341
+19
| +1% | +$987 |
|
1229
Agios Pharmaceuticals
AGIO
$1.82B
| $77K | ﹤0.01% |
1,501
-78
| -5% | -$3.99K |
|
1230
Tronox
TROX
$909M
| $77K | ﹤0.01% |
5,090
+1,719
| +51% | +$27.6K |
|
|
HSNI
1231
DELISTED
HSN, Inc.
HSNI
| $77K | ﹤0.01% |
2,428
+1,874
| +338% | +$64.8K |
|
1232
Brown & Brown
BRO
$24B
| $76K | ﹤0.01% |
3,516
+442
| +14% | +$9.47K |
|
|
AGN.PRA
1233
DELISTED
Allergan plc
AGN.PRA
| $76K | ﹤0.01% |
88
| – | – |
|
1234
Acco Brands
ACCO
$399M
| $75K | ﹤0.01% |
6,452
+4,567
| +242% | +$56.8K |
|
1235
iShares Biotechnology ETF
IBB
$9.18B
| $74K | ﹤0.01% |
720
+24
| +3% | +$2.36K |
|
1236
Paycom
PAYC
$7.86B
| $74K | ﹤0.01% |
1,076
| – | – |
|
1237
PJT Partners
PJT
$4.36B
| $74K | ﹤0.01% |
+1,845
| New | +$69K |
|
|
WP
1238
DELISTED
Worldpay, Inc.
WP
| $74K | ﹤0.01% |
1,154
-20
| -2% | -$1.26K |
|
|
MOMO
1239
Hello Group
MOMO
$879M
| $73K | ﹤0.01% |
+1,976
| New | +$75.8K |
|
1240
Tower Semiconductor
TSEM
$26.5B
| $73K | ﹤0.01% |
+3,049
| New | +$71.9K |
|
|
BGFV
1241
DELISTED
Big 5 Sporting Goods
BGFV
| $72K | ﹤0.01% |
+5,554
| New | +$79.7K |
|
|
CIM
1242
Chimera Investment
CIM
$1.06B
| $72K | ﹤0.01% |
1,285
| – | – |
|
1243
Ameris Bancorp
ABCB
$5.92B
| $71K | ﹤0.01% |
1,465
+233
| +19% | +$10.7K |
|
1244
Cathay General Bancorp
CATY
$4.27B
| $71K | ﹤0.01% |
1,875
+22
| +1% | +$826 |
|
1245
iShares TIPS Bond ETF
TIP
$14.5B
| $71K | ﹤0.01% |
625
-1,820
| -74% | -$208K |
|
1246
NVR
NVR
$16.6B
| $70K | ﹤0.01% |
+29
| New | +$65.4K |
|
1247
NorthWestern Energy
NWE
$4.24B
| $70K | ﹤0.01% |
1,145
+17
| +2% | +$1.04K |
|
1248
A.O. Smith
AOS
$8.25B
| $69K | ﹤0.01% |
1,239
-463
| -27% | -$25K |
|
1249
ServiceNow
NOW
$118B
| $69K | ﹤0.01% |
3,240
-1,430
| -31% | -$28K |
|
1250
Ormat Technologies
ORA
$6.02B
| $69K | ﹤0.01% |
1,182
| – | – |
|
Similar funds
TIM
SC
TCA
CIM
CCMT
LAMI
BAMF
DCP
Oppenheimer Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Oppenheimer Asset Management held 1,787 positions worth $3.62B, up 3.1% from $3.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Oppenheimer Asset Management's Q2 2017 filing shows 81 new, 723 increased, 742 reduced and 106 closed positions. Its largest new stake was Evolent Health: 58,930 shares worth $1.49M. The largest sale was Microsoft, an estimated $7.8M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Oppenheimer Asset Management's largest Q2 2017 buy was Evolent Health: 58,930 shares worth $1.49M.
- Oppenheimer Asset Management added most to Johnson Controls International in Q2 2017, an estimated $9.09M increase.
- Oppenheimer Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $7.8M.
- Oppenheimer Asset Management fully exited Nippon Telegraph & Telephone in Q2 2017, selling an estimated $3.36M.
- Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.62B portfolio in Q2 2017.
- Oppenheimer Asset Management opened 81 new positions and closed 106 in Q2 2017.
- Oppenheimer Asset Management's portfolio value rose 3.1% quarter-over-quarter to $3.62B.
Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.